Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Revenue (Tables)

v3.23.3
Note 6 - Revenue (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

Three Months Ended September 30,

 
   

2023

   

2022

 

Sales of products, net:

               

Pharmacy prescription and other revenue, net of PBM fees

  $ 9,887,890     $ -  

e-Commerce revenue

    2,930,721       2,630,826  

Sub total

    12,818,611       2,630,826  

Revenues from services:

               

Pharmacy 340B contract revenue

    2,471,560       -  
                 

Revenues, net

  $ 15,290,171     $ 2,630,826  
   

Nine Months Ended September 30,

 
   

2023

   

2022

 

Sales of products, net:

               

Pharmacy prescription and other revenue, net of PBM fees

  $ 9,887,890     $ -  

e-Commerce revenue

    8,764,237       9,080,083  

Sub total

    18,652,127       9,080,083  

Revenues from services:

               

Pharmacy 340B contract revenue

    2,471,560       -  
                 

Revenues, net

  $ 21,123,687     $ 9,080,083